HomeInsightsStock Comparison

Gujarat Themis Biosyn Ltd vs Vivo Bio Tech Ltd Stock Comparison

Gujarat Themis Biosyn Ltd vs Vivo Bio Tech Ltd Stock Comparison

Last Updated on: May 15, 2025

Key Highlights

  • The Latest Trading Price of Gujarat Themis Biosyn Ltd is ₹ 314.45 as of 14 May 15:30.
  • The P/E Ratio of Gujarat Themis Biosyn Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Vivo Bio Tech Ltd changed from 5.6 on March 2020 to 25.2 on March 2024 . This represents a CAGR of 35.10% over 5 years.
  • The Market Cap of Gujarat Themis Biosyn Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Vivo Bio Tech Ltd changed from ₹ 25 crore on March 2020 to ₹ 63.89 crore on March 2024 . This represents a CAGR of 20.64% over 5 years.
  • The revenue of Gujarat Themis Biosyn Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Vivo Bio Tech Ltd for the Dec '24 is ₹ 12.22 crore as compare to the Sep '24 revenue of ₹ 16.67 crore. This represent the decline of -26.69%.
  • The ebitda of Gujarat Themis Biosyn Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Vivo Bio Tech Ltd for the Dec '24 is ₹ 5.55 crore as compare to the Sep '24 ebitda of ₹ 10.22 crore. This represent the decline of -45.69%.
  • The net profit of Gujarat Themis Biosyn Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Vivo Bio Tech Ltd changed from ₹ 0.14 crore to ₹ 0.82 crore over 7 quarters. This represents a CAGR of 174.59% .
  • The Dividend Payout of Gujarat Themis Biosyn Ltd changed from 10.12 % on March 2020 to 12.27 % on March 2024 . This represents a CAGR of 3.93% over 5 yearsThe Dividend Payout of Vivo Bio Tech Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Gujarat Themis Biosyn Ltd

  • Promoted by Kantilal Shah, Gujarat Themis Biosyn Limited was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Company commenced production in August 1985.
  • It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is being actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007. Initially manufacturing the antibiotic, erythromycin, GTBL obtained licences to manufacture bulk drugs like rifampicin, cephalexin, griseofulvin and their formulations in 1990.

About Vivo Bio Tech Ltd

  • Vivo Bio Tech Limited, established in February, 1987 is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD, AAALAC & IND guidelines.
  • The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetics & toxicokinetic studies etc.
  • Their experienced & talented scientists offer advice on defining drug development paths tailored to specific molecules. The Company stands as a premier and primary provider of SPF lab animals in India.
  • It holds the distinction of being the largest breeder and distributor of rodent models, in addition to offering custom rodent models and stem cell products through Cyagen Biosciences.
  • The Company serves as an authorized distributor of lab animal diets from Special Diets Services (UK) in India.

Gujarat Themis Biosyn Ltd News Hub

News

Gujarat Themis Biosyn to convene board meeting

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 14 F...

Read more

11 Feb 2025 10:53

News

Board approved merger of Gujarat Themis Biosyn with Themis Medicare

The Board of Directors of Gujarat Themis Biosyn (GTBL) and Themis Medicare (TML) have appr...

Read more

19 Nov 2024 09:10

News

Gujarat Themis Biosyn schedules board meeting

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 25 O...

Read more

19 Oct 2024 09:25

News

Gujarat Themis' Q1 PAT falls over 25% YoY to Rs 13 crore

This decline was primarily driven by a 21.7% YoY drop in net sales to Rs 38.83 crore. Tota...

Read more

27 Jul 2024 09:25

News

Board of Gujarat Themis Biosyn appoints director

The Board of Gujarat Themis Biosyn has approved the appointment of K. G. Ananthakrishnan (...

Read more

26 Jul 2024 19:50

News

Gujarat Themis Biosyn schedules board meeting

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 26 J...

Read more

17 Jul 2024 10:09

Vivo Bio Tech Ltd News Hub

News

Vivo Bio Tech schedules board meeting

Vivo Bio Tech will hold a meeting of the Board of Directors of the Company on 19 May 2025....

Read more

14 May 2025 16:11

News

Vivo Bio Tech EGM scheduled

Vivo Bio Tech announced that an Extra Ordinary General Meeting (EGM) of the Company will b...

Read more

10 Jan 2025 12:43

News

Vivo Bio Tech schedules board meeting

Vivo Bio Tech will hold a meeting of the Board of Directors of the Company on 9 January 20...

Read more

02 Jan 2025 17:34

News

Vivo Bio Tech to convene board meeting

Vivo Bio Tech will hold a meeting of the Board of Directors of the Company on 21 November ...

Read more

16 Nov 2024 10:07

News

Vivo Bio Tech to hold board meeting

Vivo Bio Tech will hold a meeting of the Board of Directors of the Company on 14 November ...

Read more

30 Oct 2024 17:01

News

Vivo Bio Tech to convene AGM

Vivo Bio Tech announced that the 37th Annual General Meeting (AGM) of the company will be ...

Read more

02 Sep 2024 09:35

SWOT Analysis Of Vivo Bio Tech Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Gujarat Themis Biosyn Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Vivo Bio Tech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Gujarat Themis Biosyn Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Gujarat Themis Biosyn Ltd and Vivo Bio Tech Ltd

Which company has a larger market capitalization, Gujarat Themis Biosyn Ltd or Vivo Bio Tech Ltd?

Market cap of Gujarat Themis Biosyn Ltd is 3,426 Cr while Market cap of Vivo Bio Tech Ltd is 73 Cr

What are the key factors driving the stock performance of Gujarat Themis Biosyn Ltd and Vivo Bio Tech Ltd?

The stock performance of Gujarat Themis Biosyn Ltd and Vivo Bio Tech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gujarat Themis Biosyn Ltd and Vivo Bio Tech Ltd?

As of May 15, 2025, the Gujarat Themis Biosyn Ltd stock price is INR ₹314.45. On the other hand, Vivo Bio Tech Ltd stock price is INR ₹40.88.

How do dividend payouts of Gujarat Themis Biosyn Ltd and Vivo Bio Tech Ltd compare?

To compare the dividend payouts of Gujarat Themis Biosyn Ltd and Vivo Bio Tech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions